Barakah Profits › United States stocks A–Z

Is DiaMedica Therapeutics Inc. (DMAC) halal?

No. DiaMedica Therapeutics Inc. (DMAC) does not pass our halal screen, as of 18 November 2026. It fails on business activity.

NASDAQ · Healthcare · Screened 18 November 2026. Its verdict has not changed since our public ledger began on 24 September 2026.

The four checks

Business activityFailFrom the 10-K (2025): The company is a clinical-stage biopharmaceutical company with no product sales revenue; its only quantifiable income is interest income from marketable securities, constituting 100% of its revenue, which is non-permissible.
Interest-bearing debtPassTotal debt is 0.0% of market cap (limit 30%).
Cash & interest-bearing securitiesPassCash & securities are 9.6% of market cap (limit 30%).
Non-permissible income (< 5%)ReviewInterest income isn't reported for this company, so this can't be read automatically. Verify in the financial notes.

Verdict history

No changes recorded since 24 September 2026.

See every change across all stocks on the public verdict ledger.

Frequently asked questions

Is DiaMedica Therapeutics Inc. stock halal?

No. DiaMedica Therapeutics Inc. (DMAC) does not pass our halal screen, as of 18 November 2026. It fails on business activity.

Why can DiaMedica Therapeutics Inc.'s halal status change?

Two of the tests compare debt and cash with the company's market value. When the share price moves, those ratios move, so a stock can cross the 30% line without the business changing at all. Its verdict has not changed since our public ledger began on 24 September 2026.

How does Barakah Profits screen stocks?

We use an AAOIFI-style screen: the business itself must be permissible, interest-bearing debt and interest-bearing cash must each be under 30% of market value, and non-permissible income must be under 5% of revenue. It is an automated estimate, not a fatwa.

Check any stock

Free halal check for US, Australian, Malaysian and Singapore stocks.

Check a stock

AAOIFI-style screen by Barakah Profits. Automated estimate, not a fatwa. Always confirm with a qualified scholar before investing. Financial data provided by Twelve Data. This is general information, not financial advice.